Barclays Maintains Overweight on Kanzhun, Raises Price Target to $20
Barclays analyst Jiong Shao maintains Kanzhun (NASDAQ:BZ) with a Overweight and raises the price target from $19 to $20.
Read original at benzingaStocks · News reference
The recruitment app operator’s revenue has slowed steadily over the last three years as it solidifies its dominant position in China image credit: Bamboo Works Key Takeaways: Kanzhun’s revenue grew 14.1%
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Barclays analyst Jiong Shao maintains Kanzhun (NASDAQ:BZ) with a Overweight and raises the price target from $19 to $20.
Read original at benzingaU.S. stocks mixed, Nasdaq up 0.1%. Abercrombie & Fitch shares surge 31.6% after beating earnings and raising forecasts. Other top gainers include Kanzhun, Capricor Therapeutics, Semtech Corp, and more.
Read original at benzingaRobert Half (RHI) stock surged 87.6% over six months, outperforming both its industry (79.8%) and the S&P 500 (11.4%). The company maintains a strong financial position with $325M in cash, positive free cash flow of $102M in Q2 2026, and a healthy current ratio of 1.47. RHI demonstrates shareholder-friendly practices through consistent dividend payments and share repurchases, though it carries a Zacks Rank #3 (Hold) rating.
Read original at zacks-investment-researchFiled: 2026-08-03 AccNo: 0000315213-26-000043 Size: 176 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarBenzinga analysts share high-yielding stocks in the industrials sector, including QUAD, RHI, and CNXC. These stocks are favored by top analysts.
Read original at benzinga